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Tracheobronchial granular cell myoblastoma(GCM) is rare. Although the tumorhas some malignant
properties, it is considered benign, and there is no consensus regarding treatment. Three cases are re-
ported here. Bronchoscopic treatment in patients withGCM may be attempted as a first approach in
case the tumor is intraluminal.
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INTRODUCTION
The first report on granular cell myoblastoma(GCM) was
by Abrikossoffin 1926 and heralded a considerable quan-
tity ofcase reports, reviews, and histologic investigations.
Frenckner, in 1938, described the firstGCM in the respi-
ratory tract. Since then, more than 60 cases have been re-
ported (1). Multicentric tracheobronchial localization of
GCM has also been described (2,3). GCM is character-
ized macroscopically by a relative small size, usually less
than 5 cm in diameter, ill-defined margins, lack of en-
capsulation, firm texture, and yellowish or greyish color
(4,5). The tumor appears to infiltrate into the surrounding
tissue, causing a rather characteristic pseudo-epithe-
liomatous hyperplasia of the overlying epithelium.
Microscopy shows closely packed nests of large cylindri-
cal cells, with eosinophilic particles of various sizes and
distribution. Currently it is believed thatGCM originates
from either a Schwann cell or its mesenchymal precursor
(5). GCM is characterized by local growth, and there is
no tendency for metastasizing to regional or mediastinal
lymph nodes. So, from the oncologic point of view, there
seems to be no need for a prompt surgical approach.
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Review of the literature on the treatment of this benign
tumor showed that there is no consensus regarding treat-
ment (1,4). Surgery has been advocated as the treatment
ofchoice (6). Others favored local treatment ofGCM (4).
We present three patients with tracheobronchial localiza-
tion ofGCM and analyze the role ofbronchoscopic treat-
ment herein.
CASE REPORTS
Case 1
A 36-year-old Caucasian woman had a history of "bron-
chitis" during infancy. For several months she had been
complaining of shortness ofbreath and cough, which per-
sisted despite treatment with inhaled steroids and 12-ag-
onists. Bronchoscopy was performed and a 1.5 by 2 cm
yellow tumor 4 cm above the carina in the membranous
part of the trachea was found. Histologic examination re-
vealed granular cell myoblastoma.
The patientwas referred to our hospital for further treat-
ment. Physical examination, laboratory results, and chest
x-rays were normal. High-resolution computed tomogra-
phy (HRCT) ofthe thorax showed nonspecific changes of
the right and left lower lobe in the parenchymal setting.
A 2-cm lesion with possible tumor extension dorsal in the
trachea was seen on the magnetic resonance imaging
(MRI) scan. Because of tumor size and location, partial224 C.L. VAN FELIUS et al.
tracheal resection and tracheoplasty were performed and
the anastomosis was covered with a pericardial patch. The
margins ofthe resected specimenwere not free fromtumor
microscopically. The postsurgical periodwas complicated
by mediastinitis and anastomotic dehiscence. The peri-
cardial patch loosened and had to be removed broncho-
scopically because of airway obstruction. Despite
microscopic residual disease, the patient is doing well
without local recurrence for a follow-up period of2 years.
CT scan and bronchoscopy were repeatedly negative for
recurrent disease.
aspiratedbarley-corn in the bronchus intermedius. The lat-
ter was easily removed.
On histologic examination the tracheobronchial lesion
was a GCM (Fig. 2A), and the lesion in the intermediate
bronchus was a typical carcinoid. HRCT showed that both
tumors were intraluminal, and no mediastinal lymph node
enlargement was seen. Because of the superficial growth
of both lesions, bronchoscopic treatment with electro-
surgery was successful (GCM: Fig. 2B) in obtaining a
complete response.
Case 2 DISCUSSION
A 64-year-old Caucasian woman had a history of chronic
obstructive pulmonary disease and hypertension. She ex-
perienced progressive dyspnea, and she complained of
coughing up whitish sputum and of left-sided pectoral
chest discomfort. She had no fever. She had a 35 pack-
yearsmoking history. The patientwas treatedwith inhaled
salbutamol and beclomethasone. Chest x-rays showed an
infiltrate of the left upper lobe.
Bronchoscopy was performed and no abnormality was
found on the left side, but a whitish tumor less than 1 cm2
was found on the carina of the fight upper lobe (Fig. 1A).
Biopsy revealed GCM. HRCT did not show tumor exten-
sion pedbronchially, and no enlarged lymph nodes were
found. Bronchoscopic electrosurgery was performed
using the argon beam coagulation technique under local
anesthesia (Fig. 1B). Follow-up has been uneventful, and
she is still free of disease after 1 year. Repeated broncho-
scopic examination was negative forGCM (Fig. 1C).
Case 3
A 40-year-old Caucasian woman had a history of partial
gastrectomybecauseofleiomyoma, hysterectomybecause
ofuterus myomatosus, andasthma treated with inhaledbe-
clomethasone and salbutamol. She had been well until 3
months before admission when she complained of dysp-
nea and coughing up yellowish sputum. She denied chest
pain, hemoptysis, and fever. There was a 2-kg weight loss.
She had been smoking 20 cigarettes daily until 1 year ago.
On physical examination, there were increased breath
sounds over the right upper lobe and a slightly prolonged
expiration. Laboratory tests and chest x-rays were normal.
Because of persistent cough, a bronchoscopy was per-
formed.
Three abnormalities were found: a white lesion on the
lateral wall ofthe tracheobronchial comerextending to the
right upper lobe orifice, a reddish pedunculated tumor on
the dorsal wall of the intermediate bronchus, and a 4-mm
GCM is a rather uncommon tumor predominantly found
in the skin, subcutaneous tissue, oral mucosa, tongue, and
breast, in which 8 to 16% were multifocal (7). Less fre-
quent localizations in other organs have been reported in
many case studies. Approximately 5 to 10% of patients
with tracheobrochialGCM have multiple lesions (8). The
age ofmost patients with a tracheobronchialGCM varies
from 30 to 50 years, and there is an equal distribution be-
tween men and women. Patients usually complain of
cough, dyspnea, chest pain, recurrent pulmonary infec-
tions, and sometimes hemoptysis (4). Radiographic in-
vestigation frequently discloses infiltrates or atelectasis
due to tumor obstruction.
In a review of 13 cases of bronchoscopic removal of
GCM, resection was advocated for tumors larger than 8
mm, and in patients with irreversible damage of the pul-
monary parenchyma distal to the lesion (6).
Bronchoscopic therapy was considered as a treatment al-
ternative if tumor size was less than 8 mm, or if major
surgerywas contraindicated. Multicentric lesions less than
10 mm should be removed bronchoscopically, and those
larger than 10 mm surgically (lobectomy, pneumonec-
tomy, or bronchoplasty). HRCT may be useful in deter-
mining tumorextent in cases ofintraluminal tumors (9,10)
and in assessing the quality ofpulmonaryparenchymadis-
tal to the lesion (11).
The finding of tumor extension is important as bron-
choscopic treatment is only potentially curative in tumors
not extending to the bronchial mucosal layers. This was
particularly true in patients with superficial squamous cell
lung cancer. Whether the same situation may apply to
GCM is unknown ( 12,13).
Successful local therapy ofGCM using the CO2 laser,
the Nd-YAG laser, and endobronchial curettage have been
reported (4,8,14). However, a report of recurrent disease
5 months after CO2 laser therapy of a 2 by cm large tra-
cheal lesion has also been published (1). The same article
referred to two successful cases ofCO2 laser treatment. InBRONCHOSCOPIC THERAPY OFGCM 225
Figure I A. A superficial whitish tumor (histologic analysis: GCM) of the right upper lobe carina. B. Immediately after treatment with argon gas co-
agulation. C. Bronchoscopic view of the same area year after treatment. No residual GCM in the histologic specimens.
all our patients, the tumor proved to be strictly intralumi-
nal, and the MRI findings for the first patient were false-
positive. Tracheoplasty in our first patient was
complicated by mediastinitis and despite microscopic
residual disease, recurrence has not occurred. This seems
to fit with GCM characteristics of a more benign nature
in the tracheobronchial tree in contrast to rare malignant
forms as have been described in other organs (15).
Our two remaining patients were treated successfully
with electrosurgery as tumors were strictly intraluminal.
The role of bronchoscopic treatment, e.g., electrosurgery
may become increasingly important in tumors located in-
traluminally (16), as we have been expanding our data in
treating occult squamous cell cancer and typical bronchial
carcinoid. To our knowledge, the third patient is the first
case of coexisting GCM and typical carcinoid of the226 C.L. VAN FELIUS et al.
Figure 2 A. A yellowish tumor (histologic analysis: GCM) on the dorsal wall of the right main bronchus extending to the right tracheobronchial cor-
ner. B. View 4 months after bronchoscopic electrosurgery. No residual GCM in the histologic specimens.BRONCHOSCOPIC THERAPY OF GCM 227
bronchus ever reported. Because of its intraluminal
growth, typical bronchial carcinoid may also be treated
bronchoscopically with curative intent (17,18).
RecurrentGCMs were was probably due to inadequate
assessment ofperibronchial tumor extension before treat-
ment.
The morbidity of bronchoscopic treatment is low, so
bronchoscopic therapy should be attempted first in pa-
tients with intraluminal lesions. This is in accordance with
several other reports published previously, justifying a
more conservative approach toward tracheobronchial
GCM, even if localizations are multiple (4,6,8).
In summary, bronchoscopic treatment ofGCM may be
attempted as the first approach for intraluminal lesions not
larger than 1 cm without peribronchial growth and in the
absence of irreversible damage of lung parenchyma.
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